Atomo Diagnostics is an Australia-based company that designs, manufactures, and commercializes in-vitro diagnostic products for the healthcare sector.
Business Model:
Revenue: $5M
Employees: 11-50
Address: 3-5 George Street
City: Leichhardt
State: new south wales
Zip: 2040
Country: AU
Atomo Diagnostics is an Australia-based company that designs, manufactures, and commercializes in-vitro diagnostic products for the healthcare sector.
Contact Phone:
Contact Email:
Listed Exchange:
Australian Securities Exchange
IPO Date:
4/16/2020
IPO Valuation:
$71M
Ticker Symbol:
AT1
IPO Price:
$0.12718414929384184/share
Amount Raised:
$19M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|